[go: up one dir, main page]

FI800506A7 - ANTICOLESTROLEMISKT AEMNE MONACOLIN K OCH FOERFARANDE FOER DESS FRAMSTAELLNING - Google Patents

ANTICOLESTROLEMISKT AEMNE MONACOLIN K OCH FOERFARANDE FOER DESS FRAMSTAELLNING

Info

Publication number
FI800506A7
FI800506A7 FI800506A FI800506A FI800506A7 FI 800506 A7 FI800506 A7 FI 800506A7 FI 800506 A FI800506 A FI 800506A FI 800506 A FI800506 A FI 800506A FI 800506 A7 FI800506 A7 FI 800506A7
Authority
FI
Finland
Prior art keywords
anticolestrolemiskt
aemne
monacolin
foerfarande foer
och foerfarande
Prior art date
Application number
FI800506A
Other languages
Finnish (fi)
Other versions
FI66427B (en
FI66427C (en
Inventor
Akira Endo
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI800506A7 publication Critical patent/FI800506A7/en
Publication of FI66427B publication Critical patent/FI66427B/en
Application granted granted Critical
Publication of FI66427C publication Critical patent/FI66427C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI800506A 1979-02-20 1980-02-20 FOERFARANDE FOER FRAMSTAELLNING AV EN NY SOM CEILING MODEL FI66427C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (en) 1979-02-20 1979-02-20 New physiologically active substance monacolin K and its production method
JP1785679 1979-02-20

Publications (3)

Publication Number Publication Date
FI800506A7 true FI800506A7 (en) 1980-08-21
FI66427B FI66427B (en) 1984-06-29
FI66427C FI66427C (en) 1984-10-10

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800506A FI66427C (en) 1979-02-20 1980-02-20 FOERFARANDE FOER FRAMSTAELLNING AV EN NY SOM CEILING MODEL

Country Status (27)

Country Link
JP (1) JPS5925599B2 (en)
KR (1) KR830002801B1 (en)
AT (1) AT373915B (en)
AU (1) AU532626B2 (en)
BE (1) BE881825A (en)
CA (1) CA1129794A (en)
CH (1) CH645890A5 (en)
DD (1) DD154494A5 (en)
DE (2) DE3051175C2 (en)
DK (2) DK149095C (en)
ES (1) ES8103171A1 (en)
FI (1) FI66427C (en)
FR (1) FR2449685B1 (en)
GB (1) GB2046737B (en)
HU (1) HU182069B (en)
IE (1) IE49743B1 (en)
IT (1) IT1175260B (en)
MX (1) MX6314E (en)
NL (1) NL191540C (en)
NO (1) NO153974C (en)
NZ (1) NZ192919A (en)
PH (1) PH15145A (en)
PL (1) PL124304B1 (en)
SE (1) SE453301B (en)
SG (1) SG6784G (en)
SU (2) SU1158048A3 (en)
ZA (1) ZA80962B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (en) * 1980-03-31 1994-11-16 三共株式会社 MB-530A derivative
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5835144A (en) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb-530b derivative and its preparation
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
WO1993017991A1 (en) * 1992-03-04 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
FI932188L (en) 1992-05-15 1993-11-16 Sankyo Co OCTAHYDRONAPTHALENOXIME DERIVATIVES FOER INHIBERING AV CHOLESTEROLBIOSYNTESEN, DERAS FRAMSTAELLNING OCH ANVAENDNING
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
UA73074C2 (en) 1998-03-20 2005-06-15 Method of controlled fermentation for production of lovastatin as hydroxy-acid
HUP0300073A3 (en) 2000-02-24 2004-10-28 Teva Gyogyszergyar Zartkoeruee Method of purifying a fermentation broth
JP2003525935A (en) 2000-03-03 2003-09-02 ビオガル ジョジセルジャール アール テー. Method for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (en) * 2000-04-12 2001-11-07 나가오카 마사시 Embryo monascus
IN192861B (en) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
ATE356554T1 (en) 2001-02-09 2007-04-15 Unilever Nv FOODS CONTAINING SOY PROTEIN AND STATIN
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (en) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 Preventive and Dietary Supplement for adult chronic disease
KR100710500B1 (en) 2005-05-18 2007-04-24 고려대학교 산학협력단 Method for producing Monacholine K using red yeast bacteria
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (en) 2012-10-12 2013-09-30 Ion Gigel Fulga COMPOSITION FOR TREATMENT OR PREVENTION OF DISLIPIDEMS
CN110331151A (en) * 2019-04-11 2019-10-15 北京工商大学 The construction method of purple Monascus mokH gene overexpression bacterial strain
CN111297938A (en) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 Method for detecting lovastatin in composition for assisting in reducing blood fat
JP2022135089A (en) * 2021-03-04 2022-09-15 小林製薬株式会社 cholesterol lowering agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SE8001339L (en) 1980-08-21
SU969702A1 (en) 1982-10-30
SE453301B (en) 1988-01-25
NL191540C (en) 1995-09-04
PL222120A1 (en) 1980-10-20
DE3006216A1 (en) 1980-09-04
ZA80962B (en) 1981-03-25
IE49743B1 (en) 1985-12-11
BE881825A (en) 1980-08-20
IT1175260B (en) 1987-07-01
ES488796A0 (en) 1981-02-16
KR830002801B1 (en) 1983-12-16
DK73080A (en) 1980-08-21
PH15145A (en) 1982-08-24
AU532626B2 (en) 1983-10-06
NO153974C (en) 1986-06-25
DK149095B (en) 1986-01-20
GB2046737B (en) 1983-01-12
CA1129794A (en) 1982-08-17
DK21889D0 (en) 1989-01-18
DD154494A5 (en) 1982-03-24
NL191540B (en) 1995-05-01
AT373915B (en) 1984-03-12
ATA92980A (en) 1983-07-15
GB2046737A (en) 1980-11-19
HU182069B (en) 1983-12-28
DE3006216C2 (en) 1985-10-31
FI66427B (en) 1984-06-29
NO153974B (en) 1986-03-17
NO800451L (en) 1980-08-21
JPS55111790A (en) 1980-08-28
MX6314E (en) 1985-04-01
AU5567380A (en) 1980-08-28
FR2449685B1 (en) 1985-06-28
DK149095C (en) 1986-06-16
IE800321L (en) 1980-08-20
SG6784G (en) 1985-02-08
DK21889A (en) 1989-01-18
NZ192919A (en) 1984-07-06
JPS5925599B2 (en) 1984-06-19
KR830002030A (en) 1983-05-21
NL8001041A (en) 1980-08-22
SU1158048A3 (en) 1985-05-23
CH645890A5 (en) 1984-10-31
PL124304B1 (en) 1983-01-31
ES8103171A1 (en) 1981-02-16
DE3051175C2 (en) 1989-12-21
FI66427C (en) 1984-10-10
FR2449685A1 (en) 1980-09-19
IT8067262A0 (en) 1980-02-20

Similar Documents

Publication Publication Date Title
FI800506A7 (en) ANTICOLESTROLEMISKT AEMNE MONACOLIN K OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801765A7 (en) BYGGNADSPLATTA OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801672A7 (en) LAENKREM OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI800238A7 (en) VAOFFLA OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801733A7 (en) NOW FLUORINERAT KATJONBYTARMEMBRAN OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI791041A7 (en) IMPREGNERAD POLYMERIZATIONKATALYSATOR FOERFARANDE FOER DESS FRAMSTAELLNING OCH DESS ANVAENDNING FOER ETHYLENEPOLYMERIZATION
FI790447A7 (en) FILTERKONSTRUKTION OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI793970A7 (en) MINERALBERIKNINGSKOMPOSITION OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI791516A7 (en) OINBUNDEN BOK MED MJUKA PAERMAR OCH FOERFARANDE FOER DESS TILLVERKNING
FI800717A7 (en) BERGBULTNINGSFOERFARANDE OCH ROERFORMIG UTVIDGNINGSBULT
FI791451A7 (en) BACKVENTIL OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI790963A7 (en) PAELSTYG OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI77067B (en) VAERMEFOERSEGLINSFIBERBANA OCH FOERFARANDE FOER DESS TILLVERKNING.
FI801812A7 (en) SPECIELLT FOER KORVFRAMSTAELLNING LAEMPAD HAOLSTAV MED STOEDBEHAOLLARE OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI800139A7 (en) LAMINERADE ARTIKLAR AV PHENOLHARTS OCH DESS FRAMSTAELLNINGSMETOD
FI801732A7 (en) FLUORINERAT KATJONBYTARMEMBRAN OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI792280A7 (en) KAPSYL FOER KAERL OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI790877A7 (en) FLAMHAERDIGT POLYSTYROLSKUM OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801351A7 (en) FAESTNINGSKROPP FOER SKENSKO OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801246A7 (en) PULVERFORMIGT BITUMENKONCENTRAT OCH DESS ANVAENDNING
FI792753A7 (en) HAN- OCH HONUTTAG INNEHAOLLANDE ELEKTRISKT KONTAKTDON OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801824A7 (en) MED OERTKAERNA FOERSEDD PASTILL OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI783403A7 (en) BADKAR OCH FOERFARANDE FOER DESS FRAMSTAELLNING
FI801382A7 (en) EXPANDERBAR ELEKTROD FOER ELECTROLYTCELLER OCH FOERFARANDE FOER DESS MONTERING
FI803250L (en) BEHAOLLARE OCH AEMNE FOER DESS KONSTRUERING

Legal Events

Date Code Title Description
MA Patent expired

Owner name: SANKYO COMPANY LIMITED